Castillon, Jorenda S.
HRN: 23-11-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2023
06/17/2023
500MG
500mg
Q6hrs
Abdominal Infection
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes